Re: IV vit. C (was Woman With Cancer Claims Vitamin C Save...)

[Guest guest]

I agree w/'s statements re: IV vit. C (IVC) and believe it's highly

effective.

According to BioImmune.com, if one uses noncorn-derived vit. C, the cancer

doesn't develop a resistance to the vit. C. 1 such product, Ascor L NC (vit.

C from cassava) can be purchased available from

http://mcguffmedical.com/images/pdf_Files/2006Catalog.pdf; 800-854-7220)

You can contact BioImmune (formerly CancerOption.com) at

bimm@...

888-663-8844 or 480-778-1618

and ask them for names of practitioners they've trained who are in your

area. I think their protocol is superb.

For more info on IVC,

www.iconmag.co.uk/alternatives_to_chemotherapy.htm (Dove Clinic)

www.mnwelldir.org/docs/cancer1/altthrpy.htm

http://www.canceraction.org.gg/index2.htm

http://healthy.net/scr/news.asp?Id=7915 (NIH)

www.lef.org/news/LefDailyNews.htm?NewsID=2705 & Section=VITAMINS & source=DHB_05

0914 & key=Body+ContinueReading

http://doctoryourself.com/cancer_hoffer.html

www.doctoryourself.com/riordan1.html

www.aidan-az.com/articles/vitaminc.pdf (Riordans)

www.annieappleseedproject.org/amcolforadin1.html (H. Riordan, 2003)

Riordan, Hugh D. (1997). High-Dose IV Ascorbate as a Cytotoxic

Chemotherapeutic Agent. ACAM 1997 Spring Conference, Tampa, FL. (audiotape)

www.newmediaexplorer.org/chris (click " Articles by Date " and 7/21/04 Vit. C

heading)

http://cancerdecisions.com/071804.html

Cameron E.

Protocol for the use of vitamin C in the treatment of cancer.

Med Hypotheses. 1991 Nov;36(3):190-4. Review.

PMID: 1787808 [PubMed - indexed for MEDLINE]

Riordan HD, Hunninghake RB, Riordan NH, JJ, Meng X, P,

Casciari JJ, MJ, Miranda-Massari JR, Mora EM, rio N, A.

Intravenous ascorbic acid: protocol for its application and use.

P R Health Sci J. 2003 Sep;22(3):287-90.

PMID: 14619456 [PubMed - indexed for MEDLINE]

Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA,

Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous

use.

Ann Intern Med. 2004 Apr 6;140(7):533-7.

PMID: 15068981 [PubMed - indexed for MEDLINE]

Jaffey M. Vitamin C and cancer: examination of the Vale of Leven trial

results using broad inductive reasoning.

Med Hypotheses. 1982 Jan;8(1):49-84.

PMID: 7038410 [PubMed - indexed for MEDLINE]

Riordan HD, Riordan NH, JA, Casciari JJ, Hunninghake R, MJ,

Mora EM, Miranda-Massari JR, rio N, A. Intravenous vitamin C as

a chemotherapy agent: a report on clinical cases.

P R Health Sci J. 2004 Jun;23(2):115-8.

PMID: 15377059 [PubMed - indexed for MEDLINE]

Head KA. Ascorbic acid in the prevention and treatment of cancer.

Altern Med Rev. 1998 Jun;3(3):174-86. Review.

PMID: 9630735 [PubMed - indexed for MEDLINE]

Padayatty SJ, Levine M. Reevaluation of ascorbate in cancer treatment:

emerging evidence, open minds and serendipity.

J Am Coll Nutr. 2000 Aug;19(4):423-5.

PMID: 10963459 [PubMed - indexed for MEDLINE]

Cameron E, ing L. Supplemental ascorbate in the supportive treatment of

cancer: Prolongation of survival times in terminal human cancer.

Proc Natl Acad Sci U S A. 1976 Oct;73(10):3685-9.

PMID: 1068480 [PubMed - indexed for MEDLINE]

Cameron E, A. Innovation vs. quality control: an 'unpublishable'

clinical trial of supplemental ascorbate in incurable cancer.

Med Hypotheses. 1991 Nov;36(3):185-9.

PMID: 1787807 [PubMed - indexed for MEDLINE]

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G,

Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R,

Mahoney D, Wilcox CS.

Ascorbic acid (Vitamin C) in the treatment of cancer.

J Med Soc N J. 1980 Jan;77(1):49. No abstract available.

PMID: 6928213 [PubMed - indexed for MEDLINE]

Pavlovic S, Fraser R. Orthomolecular oncology: a mechanistic view of

intravenous ascorbate's chemotherapeutic activity.

P R Health Sci J. 2002 Mar;21(1):39-41. Review.

PMID: 12013679 [PubMed - indexed for MEDLINE]

Block,Md Mark Mead, MS. " Vitamin C in Alternative Cancer Treatment:

Historical Background " . Integrative Cancer Therapies 2(2);2003 pp 147-154.

Padayatty S, Hugh D. Riordan, He Sun. Vitamin C Pharmacokinetics:

Implications for Oral and Intravenous Use " . ls of Internal Medicine

2004; 140: 533-537

Tamayo C, MA " Vitamin C as cancer treatment " . Alternative

Therapy in Health & Medicine, 2003 May-Jun;9(3):94-101.

Padayatty S, " Reevaluation of Ascorbate in Cancer Treatment: Emerging

evidence, Open Minds and Serendipity, " Journal of the American College of

Nutrition Vol.19,No.4, 423-425 (2000).

[Guest guest]

Wow, thanks for all that info. There is certainly alot out about it.

Interesting to see that one of the articles is by Block, one of

the premier MDs using alternative approaches, located here in Chicago.

(I met him back when he was studying for his med boards (a number of

years ago), and I keep in touch with one of his research associates.)

  Posted by: " Leonard " leonardleonard1@... leonardleonard1

  Date: Sat Dec 16, 2006 7:28 am ((PST))

I agree w/'s statements re: IV vit. C (IVC) and believe it's

highly effective.

According to BioImmune.com, if one uses noncorn-derived vit. C, the

cancer doesn't develop a resistance to the vit. C. 1 such product, Ascor

L NC (vit. C from cassava) can be purchased available from

http://mcguffmedical.com/images/pdf_Files/2006Catalog.pdf; 800-854-7220)

You can contact BioImmune (formerly CancerOption.com) at

bimm@...

888-663-8844 or 480-778-1618

and ask them for names of practitioners they've trained who are in your

area. I think their protocol is superb.

For more info on IVC,

www.iconmag.co.uk/alternatives_to_chemotherapy.htm (Dove Clinic)

www.mnwelldir.org/docs/cancer1/altthrpy.htm

http://www.canceraction.org.gg/index2.htm

http://healthy.net/scr/news.asp?Id=7915 (NIH)

www.lef.org/news/LefDailyNews.htm?NewsID=2705 & Section=VITAMINS & source=DHB_05

0914 & key=Body+ContinueReading

http://doctoryourself.com/cancer_hoffer.html

www.doctoryourself.com/riordan1.html

www.aidan-az.com/articles/vitaminc.pdf (Riordans)

www.annieappleseedproject.org/amcolforadin1.html (H. Riordan, 2003)

Riordan, Hugh D. (1997). High-Dose IV Ascorbate as a Cytotoxic

Chemotherapeutic Agent. ACAM 1997 Spring Conference, Tampa, FL.

(audiotape) www.newmediaexplorer.org/chris (click " Articles by Date " and

7/21/04 Vit. C heading)

http://cancerdecisions.com/071804.html

Cameron E.

  Protocol for the use of vitamin C in the treatment of cancer. Med

Hypotheses. 1991 Nov;36(3):190-4. Review. PMID: 1787808 [PubMed -

indexed for MEDLINE] Riordan HD, Hunninghake RB, Riordan NH, JJ,

Meng X, P, Casciari JJ, MJ, Miranda-Massari JR, Mora EM,

rio N, A. Intravenous ascorbic acid: protocol for its

application and use. P R Health Sci J. 2003 Sep;22(3):287-90. PMID:

14619456 [PubMed - indexed for MEDLINE] Padayatty SJ, Sun H, Wang Y,

Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C

pharmacokinetics: implications for oral and intravenous use.

Ann Intern Med. 2004 Apr 6;140(7):533-7. PMID: 15068981 [PubMed -

indexed for MEDLINE] Jaffey M. Vitamin C and cancer: examination of the

Vale of Leven trial results using broad inductive reasoning. Med

Hypotheses. 1982 Jan;8(1):49-84.

PMID: 7038410 [PubMed - indexed for MEDLINE]

Riordan HD, Riordan NH, JA, Casciari JJ, Hunninghake R,

MJ, Mora EM, Miranda-Massari JR, rio N, A. Intravenous

vitamin C as a chemotherapy agent: a report on clinical cases. P R

Health Sci J. 2004 Jun;23(2):115-8.

PMID: 15377059 [PubMed - indexed for MEDLINE]

Head KA. Ascorbic acid in the prevention and treatment of cancer. Altern

Med Rev. 1998 Jun;3(3):174-86. Review. PMID: 9630735 [PubMed - indexed

for MEDLINE] Padayatty SJ, Levine M. Reevaluation of ascorbate in cancer

treatment: emerging evidence, open minds and serendipity. J Am Coll

Nutr. 2000 Aug;19(4):423-5.

PMID: 10963459 [PubMed - indexed for MEDLINE]

Cameron E, ing L. Supplemental ascorbate in the supportive treatment

of cancer: Prolongation of survival times in terminal human cancer. Proc

Natl Acad Sci U S A. 1976 Oct;73(10):3685-9. PMID: 1068480 [PubMed -

indexed for MEDLINE] Cameron E, A. Innovation vs. quality

control: an 'unpublishable' clinical trial of supplemental ascorbate in

incurable cancer. Med Hypotheses. 1991 Nov;36(3):185-9.

PMID: 1787807 [PubMed - indexed for MEDLINE]

Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F,

Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi

A, Greenspan R, Mahoney D, Wilcox CS.

  Ascorbic acid (Vitamin C) in the treatment of cancer. J Med Soc N

J. 1980 Jan;77(1):49. No abstract available. PMID: 6928213 [PubMed -

indexed for MEDLINE] Pavlovic S, Fraser R.   Orthomolecular oncology:

a mechanistic view of intravenous ascorbate's chemotherapeutic activity.

P R Health Sci J. 2002 Mar;21(1):39-41. Review. PMID: 12013679 [PubMed -

indexed for MEDLINE]

Block,MD Mark Mead, MS. " Vitamin C in Alternative Cancer

Treatment: Historical Background " . Integrative Cancer Therapies

2(2);2003 pp 147-154. Padayatty S, Hugh D. Riordan, He Sun. Vitamin C

Pharmacokinetics: Implications for Oral and Intravenous Use " . ls of

Internal Medicine 2004; 140: 533-537

Tamayo C, MA " Vitamin C as cancer treatment " . Alternative

Therapy in Health & Medicine, 2003 May-Jun;9(3):94-101. Padayatty S,

" Reevaluation of Ascorbate in Cancer Treatment: Emerging evidence, Open

Minds and Serendipity, " Journal of the American College of Nutrition

Vol.19,No.4, 423-425 (2000).